Cochlear | COH - Ebitda

Stock Price
94.90
Daily Change
-2.45 -2.52%
Monthly
-43.15%
Yearly
-64.64%
Q2 Forecast
95.52

Cochlear reported AUD306.4M in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Ansell USD 185.8M 7M Dec/2025
Avita Medical AUD -9.69M 12.21M Dec/2025
Cochlear AUD 306.4M 13.5M Dec/2025
CSL USD 3.13B 1.17B Dec/2025
Fisher Paykel Healthcare NZD 364M 78.5M Jun/2025
Healius AUD 74.9M 40.3M Jun/2025
Integral Diagnostics AUD 46.27M 3.52M Jun/2024
Mayne Pharma AUD 20.9M 5.2M Jun/2025
Mesoblast USD -20.3M 2.51M Dec/2025
Monash IVF AUD 30.74M 4.77M Jun/2025
Nanosonics AUD 12.49M 1.13M Dec/2025
Polynovo AUD 3.89M 100K Dec/2025
Ramsay Health Care AUD 1.12B 10.6M Dec/2025
Regis Healthcare AUD 70.59M 12.81M Dec/2025
ResMed USD 547.48M 27.46M Dec/2025
Sigma Healthcare AUD 19.96M 5.15M Jul/2024
Somnomed AUD 764.45K 479.23K Jun/2023
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Telix Pharmaceuticals AUD 18.42M 14.82M Dec/2025